Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksELTA.L Regulatory News (ELTA)

  • There is currently no data for ELTA

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Epiris announces the sale of Audiotonix

3 Feb 2017 07:00

RNS Number : 9334V
Electra Private Equity PLC
03 February 2017
 

PRESS RELEASE

3 February 2017

 

 

Epiris announces the sale of Audiotonix

 

Epiris is pleased to announce that it has agreed the sale of Audiotonix, a leading manufacturer of audio mixing consoles, to Astorg, a leading European private equity firm. The transaction is anticipated to close in the first quarter of 2017, subject to regulatory approvals.

 

Electra Private Equity PLC ("Electra") is expected to receive proceeds from the sale of £203 million, an uplift of £62 million or 44% and equivalent to an increase in its NAV of 133 pence per share on the valuation of the investment at 30 September 2016. This equates to a return of 4.8x original cost* and an IRR of 51%, assuming completion by the end of March.

 

Audiotonix is the global market leader in the design and manufacture of audio mixing consoles for live events and broadcast sound. Its three premium brands (Allen & Heath, Calrec and DiGiCo) support live sound for a variety of purposes such as concerts, TV broadcasting, theatre shows and major international live events.

 

Epiris initially invested £42 million on Electra's behalf in the acquisition of Allen & Heath in 2013. This was followed by the acquisition of Calrec in March 2014 and a merger with DiGiCo in August of that year to form Audiotonix. Epiris had identified both Calrec and DiGiCo as add-on opportunities prior to investing in Allen & Heath. These three transactions have created a market leader with a strong growth profile.

 

Charles Elkington, Partner at Epiris, said:

 

"This has been a fantastic deal for Epiris and its investors, and clearly demonstrates our strategy in action.

 

"Through structured investment across three valuable brands we have created a global market leader with strong growth prospects. When we made the initial investment we had a clear strategy based on M&A, operational improvement and strategic focus. We have delivered this with two add-on acquisitions, a reorganised supply chain, and successful investment in sales and marketing as well as new product development. As a result the business has more than quadrupled earnings since 2013.

 

"The management team, under James Gordon's passionate and insightful leadership, is exceptional and we wish them all the best for the future."

 

James Gordon, CEO of Audiotonix, said:

 

"Epiris have been an extremely supportive and engaged partner. Their vision and leadership in combining the three businesses and subsequent contribution to the evolution of the group has been invaluable. We now have a solid foundation from which to push into the next stage of our development."

 

Charles Elkington and Ian Wood are responsible for the investment and the exit of Audiotonix. Robert W. Baird advised on the sale with Taylor Wessing providing legal advice.

 

Epiris refers to Epiris Managers LLP acting on behalf of its client Electra Private Equity PLC.

 

Ends 

 

 

 

For further information please contact:

Andrew Honnor, Matthew Goodman, Matthieu Roussellier, Greenbrook Communications +44 (0)20 7952 2000

Nicholas Board and Andrew Kenny, Epiris +44 (0)20 7306 3902

 

 

Note to Editors:

 

About Epiris

Epiris is a top-decile private equity fund manager*.

 

Epiris, together with its predecessor firms, has managed the business and affairs of Electra Private Equity PLC, a listed private equity investment trust, for four decades. Epiris has also managed private equity investment programmes for pension funds, financial institutions and family offices. During this time Epiris has invested in excess of £5 billion in over 200 deals. As at 30 September 2016, the firm had funds under management of

£2.4 billion.

 

Epiris' flexible investment strategy has allowed it to invest broadly across the private equity market, including in buyouts and co-investments, secondaries and debt assets.

 

In respect of buyouts and co-investments and loan-to-own debt investments made since 2011, Epiris has delivered a gross IRR of 37%**.

 

For further information please visit www.epiris.co.uk.

 

Issued by Epiris Managers LLP which is authorised and regulated by the Financial Conduct Authority.

 

* Refers to the 2009 and 2012 investment pools comprising Buyout & Co-investment, Secondary and Debt investments managed on behalf of Electra Private Equity PLC; comparator data supplied by Preqin.

 

** As at 30 September 2016 adjusted for subsequent investments and realisations. Gross IRR does not reflect adjustments for investment management and administration costs. Past performance is no guarantee of future results.

 

About Astorg

Astorg is a European private equity firm with total funds under management of over €4 billion. Astorg seeks to partner with entrepreneurial management teams to acquire European companies and create value through the provision of strategic guidance, experienced governance and adequate capital. Astorg enjoys a distinct entrepreneurial culture, a long-term shareholder perspective, and a lean decision-making body enhancing its reactivity. Though not specialized, Astorg has gathered a valuable industry expertise in healthcare, business-to-business professional services, and technology-based industrial companies. Astorg has offices in London, Paris and Luxembourg, plus Senior Advisors based in Zurich and Frankfurt.

 

For further information about Astorg, please visit www.astorg.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DISEAFAAEDKXEAF
Date   Source Headline
24th Jan 20226:15 pmRNSElectra Private Equity
24th Jan 20223:37 pmRNSDirectorate Change
24th Jan 20227:00 amRNSChange of Name
21st Jan 20222:34 pmRNSChange of Accounting Reference Date
19th Jan 20224:23 pmRNSHolding(s) in Company
14th Jan 20223:47 pmRNSHolding(s) in Company
14th Jan 20223:44 pmRNSDirector/PDMR Shareholding
13th Jan 20221:32 pmRNSHolding(s) in Company
13th Jan 20229:56 amRNSIssue of Equity
10th Jan 20227:00 amRNSUnbound Group planned AIM listing; trading update
30th Dec 20214:35 pmRNSPrice Monitoring Extension
30th Dec 202112:14 pmRNSResult of General Meeting
13th Dec 20213:31 pmRNSHotter Shoes - Extension of Loan Facilities
9th Dec 20214:32 pmRNSPublication of Circular; Notice of General Meeting
9th Dec 20217:00 amRNSRelated Party Transaction; Update on Circular
8th Dec 20214:40 pmRNSSecond Price Monitoring Extn
8th Dec 20214:35 pmRNSPrice Monitoring Extension
6th Dec 20216:18 pmRNSHolding(s) in Company
2nd Dec 20211:57 pmRNSResearch Note - Edison Investment Research Limited
2nd Dec 20211:20 pmRNSEdison review on Electra Private Equity (ELTA)
2nd Dec 202112:46 pmRNSSlides on Interim Results/Unbound Strategy
2nd Dec 20217:00 amRNSSecond Interim Report & Accounts to 30 Sept 2021
29th Nov 20217:00 amRNSPresentation on interim results/Unbound strategy
11th Nov 20214:40 pmRNSSecond Price Monitoring Extn
11th Nov 20214:35 pmRNSPrice Monitoring Extension
8th Nov 20217:43 amRNSHolding(s) in Company
2nd Nov 20217:00 amRNSDemerger complete; update on board & other matters
1st Nov 202112:14 pmRNSResult of Meeting
27th Oct 20215:30 pmRNSElectra Private Equity
15th Oct 202112:03 pmRNSCircular re proposed demerger of Hostmore plc
15th Oct 20217:00 amRNSProposed Demerger of Hostmore plc
28th Sep 20217:00 amRNSEdison issues update on Electra Private Equity
27th Sep 20213:05 pmRNSResearch Note - Edison Investment Research Limited
17th Sep 20219:54 amRNSUnbound Group Capital Markets Day Recording
16th Sep 20217:00 amRNSHostmore Trading Update and Board Composition
15th Sep 20217:00 amRNSCapital Markets Day for Unbound Group
17th Aug 20217:00 amRNSRealisation strategy; Hotter Shoes trading update
28th Jul 20214:21 pmRNSHolding(s) in Company
27th Jul 20219:13 amRNSHolding(s) in Company
19th Jul 202111:52 amRNSHolding(s) in Company
2nd Jul 20214:19 pmRNSHolding(s) in Company
1st Jul 20215:38 pmRNSDirector/PDMR Shareholding
1st Jul 202111:26 amRNSHolding(s) in Company
1st Jul 202111:24 amRNSHolding(s) in Company
29th Jun 20214:32 pmRNSHolding(s) in Company
29th Jun 202111:54 amRNSCapital Markets Day Materials
28th Jun 20218:59 amRNSConfirmation of Capital Markets Day
18th Jun 20213:40 pmRNSDirector/PDMR Shareholding
18th Jun 20213:38 pmRNSHolding(s) in Company
18th Jun 20213:36 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.